(Q39238241)

10 September 2017

title

Lithium: A classic drug-Frequently discussed, but, sadly, seldom prescribed! (English)

1 reference

10 September 2017

Olga Zivanovic

1

1 reference

10 September 2017

publication date

1 April 2017

1 reference

Australian and New Zealand Journal of Psychiatry

10 September 2017

published in

1 reference

10 September 2017

volume

51

1 reference

10 September 2017

issue

9

1 reference

10 September 2017

page(s)

886-896

1 reference

Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Factors associated with treatment nonadherence among US bipolar disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Lithium carbonate response in depression. Prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

What is a "mood stabilizer"? An evidence-based response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Stability of lithium treatment in bipolar disorder - long-term follow-up of 346 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Treatment of psychosis and mania in the postpartum period

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Trends in the treatment of bipolar disorder by outpatient psychiatrists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Treatment-emergent adverse events associated with atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Grand challenges in global mental health

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Prophylactic lithium in affective disorders. Controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Maintenance treatment in bipolar disorder: a reassessment of lithium as the first choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Treatment of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Lithium specificity in bipolar illness: a classic agent for the classic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Treatment of rapid-cycling bipolar disorder: are antidepressants mood destabilizers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Antidepressants in bipolar disorder: the case for caution

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Maintenance therapies in bipolar disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Benefits and limitations of antidepressants and traditional mood stabilizers for treatment of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

The impact of the discovery of lithium on psychiatric thought and practice in the USA and Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Suicide risk in bipolar disorder during treatment with lithium and divalproex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Lithium Response in Unipolar Versus Bipolar Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Lithium response across generations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Lithium vs. valproate vs. olanzapine vs. quetiapine as maintenance monotherapy for bipolar disorder: a population-based UK cohort study using electronic health records

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

The long-term natural history of the weekly symptomatic status of bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Lithium in drinking water and suicide mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Changes in mood stabilizer prescription patterns in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Lithium treatment and risk of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Nationwide and population-based prescription patterns in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Bipolar Disorder in Pregnancy and Postpartum: Principles of Management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Bipolar disorder: new perspectives in health care and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Psychotropic drug prescription patterns among patients with bipolar I disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Lithium toxicity profile: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Is lithium in a class of its own? A brief profile of its clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

The science and practice of lithium therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Atypical mood stabilizers: a new role for neuroleptics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Potential mechanisms of action of lithium in bipolar disorder. Current understanding

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Understanding needs, interactions, treatment, and expectations among individuals affected by bipolar disorder or schizophrenia: the UNITE global survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Lithium in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Lithium: evidence reconsidered

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

More robust evidence for the efficacy of lithium in the long-term treatment of bipolar disorder: should lithium (again) be recommended as the single preferred first-line treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Which antidepressants flick the switch?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Influence of atypical features on the quality of prophylactic effectiveness of long-term lithium treatment in bipolar disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Lithium prophylaxis: myths and realities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

The early European lithium studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

The treatment of manic psychoses by the administration of lithium salts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Olanzapine in the prevention of postpartum psychosis and mood episodes in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

The history of lithium therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Efficacy of lithium as acute treatment of manic-depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Lithium increases susceptibility of muscle glucose transport to stimulation by various agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

What happened to lithium? Antidepressant augmentation in clinical settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Risk of Postpartum Relapse in Bipolar Disorder and Postpartum Psychosis: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Prevention of postpartum episodes in women with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Lithium in mood disorders: increasing evidence base, declining use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Low-dose lithium uptake promotes longevity in humans and metazoans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

Is the safety of lithium no longer in the balance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867417695889

21 January 2018

Identifiers

DOI

10.1177/0004867417695889

1 reference

10 September 2017

1 reference